GV1001 Induces Apoptosis by Reducing Angiogenesis in Renal Cell Carcinoma Cells Both In Vitro and In Vivo
Author:
Funder
Korea Government (MSIP)
Publisher
Elsevier BV
Subject
Urology
Reference30 articles.
1. Choosing the right cell line for renal cell cancer research;Brodaczewska;Mol Cancer,2016
2. Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis;Hamada;Mol Clin Oncol,2015
3. Novel approaches in the therapy of metastatic renal cell carcinoma;Lam;World J Urol,2005
4. Immunotherapy for renal cell carcinoma;Itsumi;Clin Dev Immunol,2010
5. Prognostic factors for survival in metastatic renal cell carcinoma: update 2008;Bukowski;Cancer,2009
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A novel telomerase-derived peptide GV1001-mediated inhibition of angiogenesis: Regulation of VEGF/VEGFR-2 signaling pathways;Translational Oncology;2022-12
2. Telomeres and Cancer;Life;2021-12-16
3. Anti-Cancer Immunotherapies Targeting Telomerase;Cancers;2020-08-12
4. Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential;Cancers;2020-07-14
5. GV1001 prevents ovarian follicle loss triggered by an anti-VEGF monoclonal antibody targeting non-small cell lung carcinoma xenografts in mice;2019-07-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3